Wang Xiaodong (CIK 1662982) reported 55 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2025-11-12). Recent activity: Sell ONC (424,073 shares), Sell ONC (148,096 shares), Sell ONC (300 shares), Sell ONC (1,100 shares), Sell ONC (507 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-11-12 | BeOne Medicines Ltd. (ONC) | Director | Sell | 424,073 | $0 |
| 2025-09-11 | BeOne Medicines Ltd. (ONC) | Director | Sell | 148,096 | $0 |
| 2025-06-25 | BeOne Medicines Ltd. (ONC) | Director | Sell | 300 | $79,050 |
| 2025-06-25 | BeOne Medicines Ltd. (ONC) | Director | Sell | 1,100 | $291,885 |
| 2025-06-25 | BeOne Medicines Ltd. (ONC) | Director | Sell | 507 | $135,151 |
| 2025-06-25 | BeOne Medicines Ltd. (ONC) | Director | Sell | 100 | $26,781 |
| 2025-06-12 | BeOne Medicines Ltd. (ONC) | Director | Sell | 100 | $26,485 |
| 2025-06-12 | BeOne Medicines Ltd. (ONC) | Director | Buy | 41,760 | $271,440 |
| 2025-06-12 | BeOne Medicines Ltd. (ONC) | Director | Sell | 2,901 | $757,741 |
| 2025-06-12 | BeOne Medicines Ltd. (ONC) | Director | Sell | 15,878 | $4.2M |
| 2025-06-12 | BeOne Medicines Ltd. (ONC) | Director | Sell | 16,094 | $4.2M |
| 2025-06-12 | BeOne Medicines Ltd. (ONC) | Director | Sell | 6,787 | $1.8M |
| 2025-06-12 | BeOne Medicines Ltd. (ONC) | Director | Buy | 98,696 | $0 |
| 2025-05-15 | BeiGene, Ltd. (BGNE) | Director | Buy | 41,760 | $271,440 |
| 2025-05-15 | BeiGene, Ltd. (BGNE) | Director | Sell | 10,221 | $2.3M |
| 2025-05-15 | BeiGene, Ltd. (BGNE) | Director | Sell | 21,235 | $4.7M |
| 2025-05-15 | BeiGene, Ltd. (BGNE) | Director | Sell | 10,104 | $2.3M |
| 2025-05-15 | BeiGene, Ltd. (BGNE) | Director | Sell | 200 | $45,136 |
| 2025-04-16 | BeiGene, Ltd. (BGNE) | Director | Buy | 41,760 | $271,440 |
| 2025-04-16 | BeiGene, Ltd. (BGNE) | Director | Sell | 995 | $236,372 |
| 2025-04-16 | BeiGene, Ltd. (BGNE) | Director | Sell | 805 | $191,976 |
| 2025-04-16 | BeiGene, Ltd. (BGNE) | Director | Sell | 2,884 | $690,747 |
| 2025-04-16 | BeiGene, Ltd. (BGNE) | Director | Sell | 5,516 | $1.3M |
| 2025-04-16 | BeiGene, Ltd. (BGNE) | Director | Sell | 2,229 | $538,326 |
| 2025-04-16 | BeiGene, Ltd. (BGNE) | Director | Sell | 15,041 | $3.6M |
Source: SEC Form 4 filings · as of 2025-11-12